浙江新农化工股份有限公司 第六届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江新农化工股份有限公司(以下简称"公司")第六届监事会第十三次会议 通知于 2025 年 4 月 11 日以电子邮件、电话等方式向公司全体监事发出。会议于 2025 年 4 月 21 日以现场方式于公司会议室召开。本次会议由公司监事会主席方 建芬女士主持，会议应出席监事 3 名，实际出席监事 3 名。 证券代码：002942 证券简称：新农股份 公告编号：2025-013 本次会议的召集、召开及表决程序符合有关法律、行政法规、部门规章、规 范性文件及《公司章程》的规定。 二、监事会会议审议情况 （一）审议通过《2024 年度监事会工作报告》 《2024 年度监事会工作报告》详见刊登在巨潮资讯网（www.cninfo.com.cn） 的相关公告。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 本议案尚需提交公司 2024 年年度股东大会审议。 （二）审议通过《2024 年度财务决算报告》 经审核，监事会认为《2024 年度 ...

Financial Performance - Total operating revenue for 2024 reached 962.27 million yuan, an increase of 17.20% compared to the previous year[5] - Operating profit was 60.35 million yuan, showing a significant growth of 304.10% year-on-year[5] - Net profit attributable to shareholders was 57.73 million yuan, reflecting a 327.50% increase from the same period last year[5] - The net profit after deducting non-recurring gains and losses was 37.18 million yuan, up 185.28% year-on-year[5] - Basic earnings per share increased to 0.38 yuan, a rise of 323.53% from the previous year[5] - The weighted average return on net assets improved to 5.06%, an increase of 7.27 percentage points year-on-year[5] Assets and Equity - Total assets at the end of the reporting period amounted to 1,615.52 million yuan, a 9.45% increase from the beginning of the period[6] - Shareholders' equity attributable to the company reached 1,165.65 million yuan, growing by 3.90% compared to the start of the period[6] Business Strategy - The company focused on enhancing channel and brand development in its formulation business, leading to revenue and profit growth in both major business segments[7] Performance Consistency - There were no significant discrepancies between the reported performance and the previous earnings forecast[8]

Financial Performance - The company expects a net profit attributable to shareholders of 40.5 million to 42.5 million RMB for Q1 2025, representing a year-on-year increase of 36.03% to 42.75% compared to 29.77 million RMB in the same period last year[2] - The net profit after deducting non-recurring gains and losses is projected to be between 35.6 million and 37.6 million RMB, reflecting a growth of 46.01% to 54.21% from 24.38 million RMB in the previous year[2] - Basic earnings per share are anticipated to be between 0.26 RMB and 0.27 RMB, up from 0.19 RMB in the same period last year[2] Operational Factors - The increase in operating performance is attributed to the rise in sales volume and prices of certain products during the reporting period[4]

新农股份（002942）公告，2025年第一季度预计归属于上市公司股东的净利润为4050万元–4250万元， 同比增长36.03%-42.75%。扣除非经常性损益后的净利润为3560万元–3760万元，同比增长 46.01%-54.21%。基本每股收益预计为0.26元/股–0.27元/股。业绩增长主要由于公司部分产品销量和价 格上涨。 ...

Group 1: Market Insights - The recent increase in the price of chlorpyrifos is attributed to tight supply from upstream intermediate manufacturers and seasonal stocking demands, leading to a notable price rise for the raw material [2] - The company maintains a good cooperative relationship with upstream raw material suppliers, which mitigates the impact of raw material price increases, ensuring stable product supply [2] Group 2: Product Performance - The thiazole zinc series, particularly the product "Bisheng® Thiazole Zinc," has been recognized as a leading product in the industry since its launch in 2009, focusing on six core crops and maintaining stable growth [3] - The market share of "Bisheng® Thiazole Zinc" in its core crop segment is still relatively low, indicating significant potential for market share enhancement [3] Group 3: Product Structure and Market Strategy - Approximately 60% of the company's formulation business consists of innovative drug products, with the remainder being generic drugs and biopesticides, primarily targeting the domestic market while also expanding into overseas markets [3] - The overseas strategy for "Bisheng® Thiazole Zinc" focuses on Southeast Asia, leveraging partnerships with multinational companies and local agrochemical firms to achieve gradual internationalization [3] Group 4: Business Model and Supply Chain - The company adheres to a "differentiation" strategy and an "integrated model centered on formulations," ensuring stable supply of key intermediates and core raw materials while enhancing quality and efficiency [3] - The integrated model fosters strategic collaboration with key customers, which is crucial for long-term business success [4]

证券代码：002942 证券简称：新农股份 公告编号：2025-009 浙江新农化工股份有限公司 关于使用闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 浙江新农化工股份有限公司（以下简称"公司"）于 2024 年 10 月 22 日召开 第六届董事会第十一次会议、第六届监事会第十次会议审议通过《关于继续使用 闲置募集资金进行现金管理的议案》，同意公司继续使用不超过 8,200 万元人民 币的募集资金进行现金管理，用于购买投资低风险、安全性高的保本型理财产品。 该额度自公司第六届董事会第十一次会议审议通过之日起 12 个月内可循环滚动 使用。公司监事会及保荐机构就该事项已发表明确的同意意见。具体内容详见公 司于 2024 年 10 月 23 日在巨潮资讯网（www.cninfo.com.cn）和《证券时报》上 刊登的相关公告（公告编号：2024-046）。 一、使用部分闲置募集资金进行现金管理到期赎回的情况 2024 年 9 月 3 日，公司向宁波银行股份有限公司台州分行营业部认购单位 结构性存款，金额 2,000 万元，投 ...

Group 1: Market Overview - The recent price increase of the pesticide chlorpyrifos is attributed to tight supply from upstream intermediates and a peak stocking season in Q1, leading to a rise in raw material prices [2] - Global demand for chlorpyrifos is approximately 40,000 tons, with a projected global sales revenue of about $5 billion in 2023, primarily used in rice, grains, and corn [2][3] Group 2: Company Production and Strategy - The company's chlorpyrifos production capacity is 6,500 tons, and it is currently operating at full capacity to meet domestic and international demand [2] - The company adheres to an "integrated development model centered on formulation business," with a focus on the fungicide product "Bisheng®" and continuous improvement in technical marketing services [4] Group 3: International Expansion - The overseas expansion of the thiazole zinc formulation is a strategic focus, particularly in the Southeast Asian rice market, with partnerships established with multinational companies and local distributors [5] - The company is actively registering products in 11 countries for thiazole zinc, having obtained 27 registration certificates in 9 countries [5] Group 4: Research and Development - The successful development of the fungicide "Bisheng®" demonstrates the company's capability in product creation and industrialization [6] - The company is focusing on the bactericide sector, building a product system centered on "Bisheng®" and strategic products like "Birui®" and "Green Health Extract®" [6] - Biological pesticides are a key strategic focus for the company, aiming for a synergistic development between biological and chemical pesticides [6]

证券代码：002942 证券简称：新农股份 公告编号：2025-007 浙江新农化工股份有限公司 关于部分回购股份注销完成暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 浙江新农化工股份有限公司（以下简称"公司"）本次注销的回购股份数量 为 142,070 股，占公司本次回购股份注销前总股本的 0.09%，本次注销完成后， 公司总股本将从 156,000,000 股变更为 155,857,930 股。 经中国证券登记结算有限责任公司深圳分公司审核确认，公司本次回购股份 注销事宜已于 2025 年 1 月 24 日办理完成。 一、本次回购股份的审批程序及实施情况 1、公司于 2021 年 9 月 26 日召开第五届董事会第十五次会议，审议通过了 《关于以集中竞价方式回购公司股份的方案》，同意公司使用自有资金以集中竞 价交易的方式回购公司发行的部分人民币普通股（A 股），回购的公司股份将用 于实施股权激励或员工持股计划。公司于 2021 年 9 月 30 日披露了《关于以集中 竞价方式回购公司股份的回购报告书》。 2、2021 年 1 ...

第六届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江新农化工股份有限公司（以下简称"公司"）第六届董事会第十三次会 议于 2025 年 1 月 20 日在公司会议室以现场结合通讯方式召开。本次董事会已于 2025 年 1 月 15 日以电子邮件、电话等方式通知公司全体董事、监事、高级管理 人员。会议由公司董事长徐群辉先生主持，会议应出席董事 9 名，实际出席董事 9 名。本次会议的召集、召开及表决程序符合有关法律、行政法规、部门规章、 规范性文件及《公司章程》的规定。 证券代码：002942 证券简称：新农股份 公告编号：2025-002 浙江新农化工股份有限公司 《关于调整公司 2024 年限制性股票激励计划相关事项的公告》详见公司指 定信息披露媒体巨潮资讯网（www.cninfo.com.cn）和《证券时报》。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 二、董事会会议审议情况 （一）审议通过《关于调整公司 2024 年限制性股票激励计划相关事项的议 案》 该议案已经董事会薪酬与考核委员会 ...